Streetbeat News

Price Targets

EXAS

Piper Sandler analyst David Westenberg maintains an Overweight rating on Exact Sciences (NASDAQ:EXAS) but lowers the price target from $90 to $80.

Portfolio Pulse from Benzinga Newsdesk

October 16, 2023 | 5:24 pm

DGX

Piper Sandler analyst David Westenberg has maintained a Neutral rating on Quest Diagnostics (NYSE:DGX) and lowered the price target from $145 to $130.

Portfolio Pulse from Benzinga Newsdesk

October 16, 2023 | 5:23 pm

CTKB

Piper Sandler analyst David Westenberg has maintained an Overweight rating on Cytek Biosciences (NASDAQ:CTKB) but lowered the price target from $15 to $10.

Portfolio Pulse from Benzinga Newsdesk

October 16, 2023 | 5:21 pm

C

Piper Sandler analyst Scott Siefers maintains a Neutral rating on Citigroup (NYSE:C) and lowers the price target from $47 to $45.

Portfolio Pulse from Benzinga Newsdesk

October 16, 2023 | 5:20 pm

AKYA

Piper Sandler analyst David Westenberg has maintained an Overweight rating on Akoya Biosciences (NASDAQ:AKYA) but lowered the price target from $14 to $11.

Portfolio Pulse from Benzinga Newsdesk

October 16, 2023 | 5:18 pm

ADPT

Piper Sandler analyst David Westenberg maintains an Overweight rating on Adaptive Biotechnologies (NASDAQ:ADPT) but lowers the price target from $14 to $13.

Portfolio Pulse from Benzinga Newsdesk

October 16, 2023 | 5:17 pm

DVN

Unusual options activity has been observed for Devon Energy (NYSE:DVN), with a large position indicating a bullish stance. The options scanner at Benzinga spotted 18 uncommon trades, with 66% bullish and 33% bearish sentiment. The whales have been targeting a price range from $45.0 to $57.5 for Devon Energy over the last 3 months. The current price of DVN is up 0.74% at $48.75. Several financial institutions have maintained their ratings on Devon Energy, with price targets ranging from $51 to $62.

Portfolio Pulse from Benzinga Insights

October 16, 2023 | 5:16 pm

PFE

BMO Capital analyst Evan David Seigerman has maintained an 'Outperform' rating on Pfizer (NYSE:PFE) but lowered the price target from $44 to $33.

Portfolio Pulse from Benzinga Newsdesk

October 16, 2023 | 5:15 pm

CMS

BMO Capital analyst James Thalacker has maintained an 'Outperform' rating on CMS Energy (NYSE:CMS), but lowered the price target from $62 to $61.

Portfolio Pulse from Benzinga Newsdesk

October 16, 2023 | 5:14 pm

CNP

BMO Capital analyst James Thalacker has maintained an Outperform rating on CenterPoint Energy (NYSE:CNP) but lowered the price target from $34 to $30.

Portfolio Pulse from Benzinga Newsdesk

October 16, 2023 | 5:12 pm